GuidelineSchmerz (Berlin, Germany)2012
[Fibromyalgia syndrome. Definition, classification, clinical diagnosis and prognosis].
Guideline in Schmerz (Berlin, Germany), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it.
- [Definition, classification, clinical diagnosis and prognosis of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].Schmerz (Berlin, Germany) · 2017Pooled it
- [Treatment of fibromyalgia syndrome with gamma-hydroxybutyrate : A randomized controlled study].Schmerz (Berlin, Germany) · 2017Trial
- Efficacy of cupping therapy in patients with the fibromyalgia syndrome-a randomised placebo controlled trial.Scientific reports · 2016Trial
- Corneal confocal microscopy in fibromyalgia syndrome: small fiber neuropathy, and treatment outcomes.Eye (London, England) · 2026Article
- [Fibromyalgia syndrome].Innere Medizin (Heidelberg, Germany) · 2026Review
- Opioids and fibromyalgia: frequency of use and factors associated with increased consumption in patients remitted to a tertiary care center.BMC musculoskeletal disorders · 2024Observational
- [Older care receivers with chronic pain : Cross-sectional study of gender-specific pain intensity and home-care provision in the city environment].Schmerz (Berlin, Germany) · 2021Article
- Fibromyalgia in Older Individuals.Drugs & aging · 2021Review
- The Search for Biomarkers in Fibromyalgia.Diagnostics (Basel, Switzerland) · 2021Review
- Assessing our approach to diagnosing Fibromyalgia.Expert review of molecular diagnostics · 2020Review
- Article
- Melatonin Plus Folic Acid Treatment Ameliorates Reserpine-Induced Fibromyalgia: An Evaluation of Pain, Oxidative Stress, and Inflammation.Antioxidants (Basel, Switzerland) · 2019Article
- Clinical significance of anti-dense fine speckled 70 antibody in patients with fibromyalgia.The Korean journal of internal medicine · 2019Article
- Cardiorespiratory fitness among adults with fibromyalgia.Breathe (Sheffield, England) · 2018Review
- [Chronic pain in general practice : Results from pain specialists].Schmerz (Berlin, Germany) · 2017Article
- Controversies and challenges in fibromyalgia: a review and a proposal.Therapeutic advances in musculoskeletal disease · 2017Review
- Diagnostic confounders of chronic widespread pain: not always fibromyalgia.Pain reports · 2017Review
- [Musculoskeletal-related chest pain].Der Internist · 2017Review
- A paradigm change to inform fibromyalgia research priorities by engaging patients and health care professionals.Canadian journal of pain = Revue canadienne de la douleur · 2017Article
- [Pain syndrome of the musculoskeletal system in children and adolescents].Zeitschrift fur Rheumatologie · 2016Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe scheduled update to the German S3 guidelines on fibromyalgia syndrome (FMS) by the Association of the Scientific Medical Societies ("Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften", AWMF; registration number 041/004) was planned starting in March 2011. MATERIALS AND
methodsThe development of the guidelines was coordinated by the German Interdisciplinary Association for Pain Therapy ("Deutsche Interdisziplinären Vereinigung für Schmerztherapie", DIVS), 9 scientific medical societies and 2 patient self-help organizations. Eight working groups with a total of 50 members were evenly balanced in terms of gender, medical field, potential conflicts of interest and hierarchical position in the medical and scientific fields. Literature searches were performed using the Medline, PsycInfo, Scopus and Cochrane Library databases (until December 2010). The grading of the strength of the evidence followed the scheme of the Oxford Centre for Evidence-Based Medicine. The formulation and grading of recommendations was accomplished using a multi-step, formal consensus process. The guidelines were reviewed by the boards of the participating scientific medical societies. RESULTS AND
conclusionThe clinical diagnosis of FMS can be established by the American College of Rheumatology (ACR) 1990 classification criteria (with tender point examination), by the modified preliminary diagnostic ACR 2010 criteria or by the diagnostic criteria of the German interdisciplinary guideline (AWMF) on FMS. The English full-text version of this article is available at SpringerLink (under "Supplemental").
Indexed as
Identifiers
22760457What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.